$INGN
Inogen Inc

2021 Q1 Form 10-Q Financial Statement

#000156459021023335 Filed on May 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $86.93M $88.49M
YoY Change -1.76% -1.9%
Cost Of Revenue $47.06M $50.12M
YoY Change -6.11% 9.46%
Gross Profit $39.87M $38.37M
YoY Change 3.93% -13.61%
Gross Profit Margin 45.87% 43.36%
Selling, General & Admin $38.00M $36.90M
YoY Change 2.98% -2.59%
% of Gross Profit 95.3% 96.18%
Research & Development $4.000M $3.600M
YoY Change 11.11% 115.7%
% of Gross Profit 10.03% 9.38%
Depreciation & Amortization $5.098M $4.462M
YoY Change 14.25% 59.7%
% of Gross Profit 12.79% 11.63%
Operating Expenses $42.01M $40.60M
YoY Change 3.46% 2.65%
Operating Profit -$2.132M -$2.234M
YoY Change -4.57% -145.99%
Interest Expense $100.0K $600.0K
YoY Change -83.33% -53.85%
% of Operating Profit
Other Income/Expense, Net -$253.0K -$60.00K
YoY Change 321.67% -104.94%
Pretax Income -$2.385M -$1.687M
YoY Change 41.38% -127.78%
Income Tax -$1.653M -$98.00K
% Of Pretax Income
Net Earnings -$732.0K -$1.589M
YoY Change -53.93% -129.97%
Net Earnings / Revenue -0.84% -1.8%
Basic Earnings Per Share -$0.03 -$0.07
Diluted Earnings Per Share -$0.03 -$0.07
COMMON SHARES
Basic Shares Outstanding 22.18M 21.92M
Diluted Shares Outstanding 22.18M 21.92M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $233.2M $208.4M
YoY Change 11.88% -12.88%
Cash & Equivalents $220.0M $208.4M
Short-Term Investments $13.14M $0.00
Other Short-Term Assets $9.700M $13.90M
YoY Change -30.22% 44.79%
Inventory $26.39M $37.60M
Prepaid Expenses
Receivables $38.43M $40.40M
Other Receivables $2.000M $2.800M
Total Short-Term Assets $309.7M $303.0M
YoY Change 2.21% -5.85%
LONG-TERM ASSETS
Property, Plant & Equipment $31.05M $19.67M
YoY Change 57.89% -29.51%
Goodwill $33.06M $32.91M
YoY Change 0.43%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $18.60M $5.502M
YoY Change 238.06% -83.28%
Total Long-Term Assets $166.8M $156.1M
YoY Change 6.83% 135.14%
TOTAL ASSETS
Total Short-Term Assets $309.7M $303.0M
Total Long-Term Assets $166.8M $156.1M
Total Assets $476.5M $459.1M
YoY Change 3.79% 18.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.61M $18.73M
YoY Change -22.01% 29.16%
Accrued Expenses $16.70M $13.50M
YoY Change 23.7% 3.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $55.50M $55.85M
YoY Change -0.62% 27.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $64.70M $55.90M
YoY Change 15.74% 150.67%
Total Long-Term Liabilities $64.70M $55.90M
YoY Change 15.74% 150.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $55.50M $55.85M
Total Long-Term Liabilities $64.70M $55.90M
Total Liabilities $120.2M $111.8M
YoY Change 7.49% 68.66%
SHAREHOLDERS EQUITY
Retained Earnings $79.85M
YoY Change 21.37%
Common Stock $267.0M
YoY Change 4.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $356.3M $347.3M
YoY Change
Total Liabilities & Shareholders Equity $476.5M $459.1M
YoY Change 3.79% 18.27%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$732.0K -$1.589M
YoY Change -53.93% -129.97%
Depreciation, Depletion And Amortization $5.098M $4.462M
YoY Change 14.25% 59.7%
Cash From Operating Activities $2.860M $540.0K
YoY Change 429.63% -129.61%
INVESTING ACTIVITIES
Capital Expenditures $1.516M $1.479M
YoY Change 2.5% 58.52%
Acquisitions
YoY Change
Other Investing Activities $6.170M $11.11M
YoY Change -44.46% -284.55%
Cash From Investing Activities $986.0K $8.899M
YoY Change -88.92% -228.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.427M 975.0K
YoY Change 354.05% -60.14%
NET CHANGE
Cash From Operating Activities 2.860M 540.0K
Cash From Investing Activities 986.0K 8.899M
Cash From Financing Activities 4.427M 975.0K
Net Change In Cash 8.052M 10.33M
YoY Change -22.01% -261.38%
FREE CASH FLOW
Cash From Operating Activities $2.860M $540.0K
Capital Expenditures $1.516M $1.479M
Free Cash Flow $1.344M -$939.0K
YoY Change -243.13% -65.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y10M6D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P1Y11M15D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y11M15D
CY2020Q1 us-gaap Revenues
Revenues
88489000
CY2020Q1 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
1299000
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
50123000
CY2020Q1 ingn Gross Profit Sales Revenue
GrossProfitSalesRevenue
36022000
CY2020Q1 ingn Gross Profit Rental Revenue
GrossProfitRentalRevenue
2344000
CY2020Q1 us-gaap Gross Profit
GrossProfit
38366000
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21916365
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21916365
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
344621000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2784000
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1088000
CY2020Q1 ingn Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
7000
CY2020Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
166000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
60000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-1589000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
509000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
347300000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2516000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
927000
CY2021Q1 ingn Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
275000
CY2021Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
91000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3866000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-732000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
450000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
356284000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-1589000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4462000
CY2020Q1 ingn Gain Loss On Write Off Of Rental Units And Other Fixed Assets
GainLossOnWriteOffOfRentalUnitsAndOtherFixedAssets
-130000
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
37000
CY2020Q1 ingn Provision For Sales Returns And Doubtful Accounts
ProvisionForSalesReturnsAndDoubtfulAccounts
3608000
CY2020Q1 ingn Health Care Organization Patient Service Revenue Adjustments
HealthCareOrganizationPatientServiceRevenueAdjustments
808000
CY2020Q1 us-gaap Inventory Write Down
InventoryWriteDown
347000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2784000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-200000
CY2021Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
265000
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-952000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12418000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10511000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2686000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3721000
CY2021Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-64000
CY2020Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-213000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8171000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3710000
CY2021Q1 ingn Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
8696000
CY2020Q1 ingn Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
2262000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-41000
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-460000
CY2021Q1 ingn Increase Decrease In Warranty Reserve
IncreaseDecreaseInWarrantyReserve
520000
CY2020Q1 ingn Increase Decrease In Warranty Reserve
IncreaseDecreaseInWarrantyReserve
1000000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
518000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
149000
CY2021Q1 ingn Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
8903000
CY2020Q1 ingn Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
4263000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
540000
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
26000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1479000
CY2020Q1 ingn Payments To Produce And Purchase Rental Equipment
PaymentsToProduceAndPurchaseRentalEquipment
735000
CY2020Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
62000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8899000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
60000
CY2020Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1088000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
173000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
975000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-89000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10325000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
208362000
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
38000
CY2021Q1 ingn Preacquisition Loss Recoveries
PreacquisitionLossRecoveries
672000
CY2020 ingn Preacquisition Loss Recoveries
PreacquisitionLossRecoveries
672000
CY2021Q1 us-gaap Cash
Cash
48706000
CY2020Q4 us-gaap Cash
Cash
52812000
CY2021Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
171308000
CY2020Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
159150000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
220014000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
211962000
CY2021Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
13136000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
19257000
CY2021Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
569000
CY2020Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
459000
CY2021Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
39756000
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
30907000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
38425000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
29717000
CY2021Q1 ingn Doubtful Accounts
DoubtfulAccounts
21000
CY2020Q4 ingn Doubtful Accounts
DoubtfulAccounts
52000
CY2021Q1 ingn Rental Revenue Adjustments
RentalRevenueAdjustments
385000
CY2020Q4 ingn Rental Revenue Adjustments
RentalRevenueAdjustments
396000
CY2021Q1 ingn Allowances For Sales Returns
AllowancesForSalesReturns
925000
CY2020Q4 ingn Allowances For Sales Returns
AllowancesForSalesReturns
742000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1331000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1190000
CY2021Q1 ingn Percentage Of Non Us Revenue Invoiced In Euros
PercentageOfNonUSRevenueInvoicedInEuros
0.793
CY2020Q1 ingn Percentage Of Non Us Revenue Invoiced In Euros
PercentageOfNonUSRevenueInvoicedInEuros
0.687
CY2021Q1 us-gaap Revenues
Revenues
86932000
CY2020Q1 us-gaap Revenues
Revenues
88489000
CY2021Q1 ingn Transfer Of Inventory To Rental Equipment
TransferOfInventoryToRentalEquipment
607000
CY2020Q1 ingn Transfer Of Inventory To Rental Equipment
TransferOfInventoryToRentalEquipment
368000
CY2021Q1 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
24210000
CY2020Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
22318000
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3541000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3743000
CY2021Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1357000
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1246000
CY2021Q1 us-gaap Inventory Net
InventoryNet
26394000
CY2020Q4 us-gaap Inventory Net
InventoryNet
24815000
CY2021Q1 us-gaap Property Plant And Equipment Salvage Value
PropertyPlantAndEquipmentSalvageValue
0
CY2021Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
935000
CY2020Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
524000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2834000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2220000
CY2021Q1 ingn Rental Equipment Allowance
RentalEquipmentAllowance
650000
CY2020Q4 ingn Rental Equipment Allowance
RentalEquipmentAllowance
575000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
78514000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
74024000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
47461000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
45794000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31053000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28230000
CY2021Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020Q4 us-gaap Goodwill
Goodwill
33165000
CY2021Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
110000
CY2021Q1 us-gaap Goodwill
Goodwill
33055000
CY2021Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
84539000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17982000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
66557000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
84580000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15783000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
68797000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
6488000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
8431000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
7856000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
7832000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
7784000
CY2021Q1 ingn Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
28166000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
66557000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12520000
CY2021Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
9666000
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
9023000
CY2020Q4 ingn Accrued Litigation Settlement Current
AccruedLitigationSettlementCurrent
8000000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9191000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7091000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
14606000
CY2021Q1 ingn Accrued Purchasing Card Liability
AccruedPurchasingCardLiability
4051000
CY2020Q4 ingn Accrued Purchasing Card Liability
AccruedPurchasingCardLiability
2468000
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
482000
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
449000
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
544000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1252000
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
29349000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
33712000
CY2021Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1166000
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4000
CY2021Q1 ingn Accrued Wages And Other Payroll Related Items Current
AccruedWagesAndOtherPayrollRelatedItemsCurrent
4873000
CY2020Q4 ingn Accrued Wages And Other Payroll Related Items Current
AccruedWagesAndOtherPayrollRelatedItemsCurrent
3796000
CY2021Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2970000
CY2020Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2642000
CY2021Q1 ingn Accrued Employee Stock Purchase Plan Deductions
AccruedEmployeeStockPurchasePlanDeductions
182000
CY2020Q4 ingn Accrued Employee Stock Purchase Plan Deductions
AccruedEmployeeStockPurchasePlanDeductions
649000
CY2021Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
options to extend the leases for up to 5 years.
CY2021Q1 ingn Rent Expense Including Short Term Lease Cost
RentExpenseIncludingShortTermLeaseCost
987000
CY2020Q1 ingn Rent Expense Including Short Term Lease Cost
RentExpenseIncludingShortTermLeaseCost
751000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
554000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
593000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
763000
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
632000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9340000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2809000
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.032
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.037
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
2878000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
2781000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
2799000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
2213000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
1564000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
8452000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20687000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1777000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
18910000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2475000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16435000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
18910000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-732000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-1589000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22181394
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21916365
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22181394
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21916365
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q1 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
64400000
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22181394
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21916365
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
341716
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
327891
CY2021Q1 ingn Weighted Average Number Of Diluted Shares Outstanding Based On Net Loss
WeightedAverageNumberOfDilutedSharesOutstandingBasedOnNetLoss
22523110
CY2020Q1 ingn Weighted Average Number Of Diluted Shares Outstanding Based On Net Loss
WeightedAverageNumberOfDilutedSharesOutstandingBasedOnNetLoss
22244256
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
373285
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
374456
CY2020 ingn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValuePerShare
11.81
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
205753
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
40.07
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
40.07
CY2021Q1 ingn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested And Exercisable Per Share Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndExercisablePerShareAverageIntrinsicValue
15.09
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
40.07
CY2021Q1 ingn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested And Expected To Vest Per Share Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndExpectedToVestPerShareAverageIntrinsicValue
15.09
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6504000
CY2021Q1 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
313000
CY2021Q1 us-gaap Contractual Obligation
ContractualObligation
313000
CY2019Q2 ingn Number Of Lawsuits
NumberOfLawsuits
2
CY2019Q4 ingn Number Of Additional Shareholder Derivative Who Filed Lawsuits
NumberOfAdditionalShareholderDerivativeWhoFiledLawsuits
3
CY2020Q1 ingn Number Of Consolidated Shareholder Derivative Lawsuits
NumberOfConsolidatedShareholderDerivativeLawsuits
4
CY2019Q2 ingn Number Of Consolidated Shareholder Derivative Lawsuits
NumberOfConsolidatedShareholderDerivativeLawsuits
2
CY2021Q1 ingn Number Of Contract Designated Hedges
NumberOfContractDesignatedHedges
22
CY2021Q1 ingn Number Of Contract Non Designated Hedges
NumberOfContractNonDesignatedHedges
2
CY2020 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-754000
CY2020 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
6885000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
14394000
CY2021Q1 ingn Contract With Customer Performance Obligations To Be Satisfied In Future Periods
ContractWithCustomerPerformanceObligationsToBeSatisfiedInFuturePeriods
1604000
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1375000
CY2020Q1 ingn Number Of Contract Designated Hedges
NumberOfContractDesignatedHedges
8
CY2020Q1 ingn Number Of Contract Non Designated Hedges
NumberOfContractNonDesignatedHedges
1

Files In Submission

Name View Source Status
0001564590-21-023335-index-headers.html Edgar Link pending
0001564590-21-023335-index.html Edgar Link pending
0001564590-21-023335.txt Edgar Link pending
0001564590-21-023335-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ingn-10q_20210331.htm Edgar Link pending
ingn-10q_20210331_htm.xml Edgar Link completed
ingn-20210331.xsd Edgar Link pending
ingn-20210331_cal.xml Edgar Link unprocessable
ingn-20210331_def.xml Edgar Link unprocessable
ingn-20210331_lab.xml Edgar Link unprocessable
ingn-20210331_pre.xml Edgar Link unprocessable
ingn-ex106_186.htm Edgar Link pending
ingn-ex311_9.htm Edgar Link pending
ingn-ex312_6.htm Edgar Link pending
ingn-ex321_8.htm Edgar Link pending
ingn-ex322_10.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending